Freenome, Inc. (FRNM) stock
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.82−0.27 (-2.68%)
Close on Nov 17, 2026Market cap $1.09BP/E –Yield –
Freenome total assets
Total assets on the balance sheet at the end of each period.
Freenome's total assets was $733.53M at Sep 30, 2026. For fiscal 2025 it was $507.05M, up 464.0% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $507.05M | +464.0% |
| FY2024 | Dec 31, 2024 | $89.90M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $733.53M | +695.6% |
| Q2 FY2026 | Jun 30, 2026 | $85.83M | -6.1% |
| Q1 FY2026 | Mar 31, 2026 | $93.33M | +3.0% |
| Q4 FY2025 | Dec 31, 2025 | $507.05M | +464.0% |
| Q3 FY2025 | Sep 30, 2025 | $92.20M | +3.6% |
| Q2 FY2025 | Jun 30, 2025 | $91.40M | +4.0% |
| Q1 FY2025 | Mar 31, 2025 | $90.63M | – |
| Q4 FY2024 | Dec 31, 2024 | $89.90M | – |
| Q3 FY2024 | Sep 30, 2024 | $89.01M | – |
| Q2 FY2024 | Jun 30, 2024 | $87.89M | – |
See a number that looks wrong?